If met with success, this may provide impetus for further investment and research into utilising other types of peptides, not only to compete with current weight loss drugs available, but for other conditions and diseases that render themselves treatable through peptide agonists
Promise treating addiction This communication spans specialties beyond what one might expect for GLP-1 drugs
Rapid life-history evolution reinforces competitive asymmetry between invasive and resident species
Given that the common gastrointestinal symptoms such as nausea, vomiting, and diarrhea could result in dehydration, hemoconcentration and increased blood viscosity, important risk factors for DVT, might contribute to the association between GLP1RAs and increased risk of DVT
With interest peaking, new versions of these drugs in development, and production ramping up globally
This finding suggests that while local injection near the hip may provide optimal results, systemic administration still offers meaningful benefits for hip recovery